邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

《中国绝经管理与绝经激素治疗指南2023版》解读

陈蓉

downloadPDF
文章导航 > 协和医学杂志  > 2023 >  14(3): 514-519
陈蓉. 《中国绝经管理与绝经激素治疗指南2023版》解读[J]. 协和医学杂志, 2023, 14(3): 514-519. doi: 10.12290/xhyxzz.2023-0190
引用本文: 陈蓉. 《中国绝经管理与绝经激素治疗指南2023版》解读[J]. 协和医学杂志, 2023, 14(3): 514-519. doi: 10.12290/xhyxzz.2023-0190
shu
CHEN Rong. Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 514-519. doi: 10.12290/xhyxzz.2023-0190
Citation: CHEN Rong. Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 514-519. doi: 10.12290/xhyxzz.2023-0190
shu

《中国绝经管理与绝经激素治疗指南2023版》解读

doi: 10.12290/xhyxzz.2023-0190

  • 中国医学科学院北京协和医院妇科内分泌与生殖中心，北京 100730

基金项目: 

中央高水平医院临床科研业务费 2022-PUMCH-B-123

详细信息
    作者简介:

    陈蓉, E-mail: chenrongpumch@163.com

  • 中图分类号: R71;R459.1

Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines

  • Gynecological Endocrinology and Reproductive Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds: 

National High Level Hospital Clinical Research Funding 2022-PUMCH-B-123

More Information

    摘要
  • 摘要: 绝经的本质是卵巢功能衰竭，其对女性健康影响重大。绝经管理的理念是“治已病”兼顾“治未病”，即缓解绝经相关症状的同时预防慢性疾病，在全面生活方式管理的基础上，在专业医务工作者的指导下，对适宜女性开展包括绝经激素治疗在内的各项医疗保健措施，从而改善和提高中老年女性的生命质量。《中国绝经管理与绝经激素治疗指南2023版》已于2023年1月正式发表，本文对该指南的核心要点尤其是主要更新点进行解读，以期更好地指导临床实践。
    Abstract: The essence of menopause is ovarian failure, which has a significant impact on women's health. The goal of menopausal management is to relieve menopause-related symptoms, and hopefully, prevent chronic diseases in old age. Based on comprehensive lifestyle management, various health care measures including menopausal hormone therapy have been carried out under the guidance of professional medical practitioners so as to improve and enhance the quality of life of middle-aged and elderly women. The 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines was officially published in January 2023, and this article interprets the core points of the guidelines, especially the main updates, in order to better guide clinical practice.
    利益冲突：作者声明不存在利益冲突
    • HTML全文
    • 参考文献(14)
  • [1] Bai R, Liu Y, Zhang L, et al. Projections of future life expectancy in China up to 2035: a modelling study[J]. Lance Public Health, 2023: S2468-2667(22)00338-3.
    [2] 中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南2023版[J]. 中华妇产科杂志, 2023, 58: 4-21. https://www.cnki.com.cn/Article/CJFDTOTAL-XHYX201806007.htm
    [3] 中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南(2018)[J]. 协和医学杂志, 2018, 9: 512-525. doi:  10.3969/j.issn.1674-9081.2018.06.007
    [4] Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual articipant meta-analysis of the worldwide epidemiological evidence[J]. Lancet, 2019, 394: 1159-1168. doi:  10.1016/S0140-6736(19)31709-X
    [5] Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases[J]. BMJ, 2020, 371: m3873. http://www.xueshufan.com/publication/3097702496
    [6] Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of Menopausal Hormone Therapy with Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials[J]. JAMA, 2020, 324: 369-380. doi:  10.1001/jama.2020.9482
    [7] The 2022 hormone therapy position statement of The North American Menopause Society[J]. Menopause, 2022, 29: 767-794.
    [8] Academic Committee of the Korean Society of Menopause, Lee SR, Cho MK, et al. The 2020 Menopausal Hormone Therapy Guidelines[J]. J Menopausal Med, 2020, 26: 69-98. doi:  10.6118/jmm.20000
    [9] Harlow SD, Gass M, Hall JE, et al. STRAW+10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging[J]. Menopause, 2012, 19: 387-395. doi:  10.1097/gme.0b013e31824d8f40
    [10] Li J, Luo M, Tang R, et al. Vasomotor symptoms in aging Chinese women: findings from a prospective cohort study[J]. Climacteric, 2020, 23: 46-52. doi:  10.1080/13697137.2019.1628734
    [11] Saccardi C, Spagnol G, Bonaldo G, et al. New Light on Endometrial Thickness as a Risk Factor of Cancer: What Do Clinicians Need to Know?[J]. Cancer Manag Res, 2022, 14: 1331-1340. doi:  10.2147/CMAR.S294